The Patent Finder

1ST Biotherapeutics, Inc.

12 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 20, 2027
    The maintenance fee for Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders (US 10,385,046) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds (US 11,744,824) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Imidazopyridinyl Compounds and Use Thereof for Treatment of Neurodegenerative Disorders (US 11,802,126) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Substituted Indazoles as Hematopoietic Progenitor Kinase 1 (HPK1) Inhibitors (US 11,834,467) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,669,246Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
In force
 · USPTO record
In forceUSPTO record
US 10,968,188Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
In force
 · USPTO record
In forceUSPTO record
US 10,385,046Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
In force
 · USPTO record
In forceUSPTO record
US 11,098,044Imidazopyridinyl Compounds and Use Thereof for Treatment of Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 11,802,126Imidazopyridinyl Compounds and Use Thereof for Treatment of Neurodegenerative Disorders
In force
 · Medium confidence
In forceMedium confidence
US 12,534,461Imidazopyridinyl Compounds and Use Thereof for Treatment of Neurodegenerative Disorders
In force
 · Low confidence
In forceLow confidence
US 11,744,8242-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
In force
 · USPTO record
In forceUSPTO record
US 11,649,255Indazoles as Hematopoietic Progenitor Kinase 1 (HPK1) Inhibitors and Methods Using Same
In force
 · High confidence
In forceHigh confidence
US 11,834,467Substituted Indazoles as Hematopoietic Progenitor Kinase 1 (HPK1) Inhibitors
In force
 · High confidence
In forceHigh confidence
US 12,304,905Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof
In force
 · USPTO record
In forceUSPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited